Stock Market Success: RAPT Therapeutics Ascends Despite Trials Setback
RAPT Therapeutics, Inc. (NASDAQ: RAPT) is currently experiencing a notable surge in its performance on the US stock market. At the latest check during the current session, RAPT stock has demonstrated a commendable increase of 19.51%, reaching $8.21. This positive trend persists despite a regulatory setback encountered in one of its clinical trials. According to […]
Stock Market Success: RAPT Therapeutics Ascends Despite Trials Setback Read More »